1. Market Research
  2. > Healthcare Market Trends

Physician Views – Are physicians getting the biosimilar education they need?

  • April 2014
  • Firstword Pharma
Report ID: 2076243

Summary

Table of Contents

Biosimilars remain one of the pharmaceutical industry's hot topics. Branded biologics account for 7 of the 10 best selling drugs globally and significant legislative momentum was provided in 2013 when the European Medicines Agency (EMA) approved its first biosimilar antibody products (versions of the anti-TNF Remicade). There may be less regulatory momentum in the US market but further insight from the FDA – including its views on interchangeability – is expected to emerge over the next 12 months.

With approval of the first biosimilar antibodies, however, there has been a steady shift in focus from the development/regulatory space to the commercial landscape. Many questions are being asked; how will biosimilars compete on price?, what sales and marketing infrastructure will be necessary to support uptake? And, increasingly, are physicians ready for biosimilars and is the industry doing enough to educate who is arguably the key stakeholder in this market?

As physician familiarity with the biosimilar concept inevitably increases, this exposure will raise further pertinent questions for the practising community; interchangeability (i.e. with branded equivalents), the extent of clinical data available for biosimilars, indication extrapolation and naming conventions will all feature prominently as more products reach the market – see ViewPoints: Money for nothing? – Indication extrapolation remains key issue for biosimilar developers and Physician Views: At least some similarity needed in biosimilar naming conventions, say majority of physicians, but caveats remain

In a bid to address these questions and concerns, industry will play a pivotal role in supporting the education of physicians around biosimilars. In turn – among other considerations – it will have to pinpoint where and how best to promote the biosimilar message and in way that is designed to address the needs of patients and physicians, rather than those companies operating in this market segment.

Reasons to purchase this study

Our latest Physician Views poll asks 5 simple questions to oncologists and rheumatologists (the most likely users of biosimilar antibodies) based in the US and EU5:

- How familiar they are with the general concept of biosimilars

- Which issue is causing them the most uncertainty in relation to the current/future use of biosimilars in day-to-day clinical practice (indication extrapolation, substitution, clinical trial design, pro-biosimilar payer policies, naming conventions, patient awareness)

- Where they obtain the majority of their information and knowledge about biosimilars (conferences, printed media, online media, pharma companies, CME providers, other physicians)

- How they rate the quality of current biosimilar medical education programmes

- How they rate the neutrality of current biosimilar medical education programmes

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

Veronica helps you find the right report:

Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

Purchase Reports From Reputable Market Research Publishers
Healthcare IT Market by Product (EHR, RIS, PACS, VNA, CPOE, HIE, Telehealth, Healthcare Analytics, Population Health Management, Supply Chain Management, CRM, Fraud Management, Claims Management) End User (Provider, Payer) - Global Forecast to 2021

Healthcare IT Market by Product (EHR, RIS, PACS, VNA, CPOE, HIE, Telehealth, Healthcare Analytics, Population Health Management, Supply Chain Management, CRM, Fraud Management, Claims Management) End User (Provider, Payer) - Global Forecast to 2021

  • $ 8150
  • Industry report
  • March 2017
  • by MarketsandMarkets

The global healthcare IT market is expected to grow at a CAGR of 15.9% from 2016 to 2021 and reach USD 280.25 billion. Growing need to manage regulatory compliance through healthcare IT solutions, government ...

Asia-Pacific Bronchoscopes Market Outlook to 2023

Asia-Pacific Bronchoscopes Market Outlook to 2023

  • $ 5995
  • Industry report
  • April 2017
  • by GlobalData

Asia-Pacific Bronchoscopes Market Outlook to 2023 Summary GlobalData’s new report, "Asia-Pacific Bronchoscopes Market Outlook to 2023", provides key market data on the Asia-Pacific Bronchoscopes market. ...

EU5 Bronchoscopes Market Outlook to 2023

EU5 Bronchoscopes Market Outlook to 2023

  • $ 5995
  • Industry report
  • April 2017
  • by GlobalData

EU5 Bronchoscopes Market Outlook to 2023 Summary GlobalData’s new report, "EU5 Bronchoscopes Market Outlook to 2023", provides key market data on the EU5 Bronchoscopes market. The report provides value, ...


Download Unlimited Documents from Trusted Public Sources

Hepatitis Statistics in the US

  • May 2017
    28 pages
  • Infectious Dise...  

    Hepatitis  

    Meningococcal  

  • United States  

    North America  

View report >

Health Care Provider Industry in Australia

  • May 2017
    2 pages
  • Health Care Pro...  

    Hospital  

  • Australia  

View report >

Health Care Provider Industry in Europe

  • May 2017
    30 pages
  • Health Care Pro...  

    Pharmaceutical  

  • Europe  

    World  

View report >

Diabetes Industry

9 days ago

Related Market Segments :

Health Care Provider
Biosimilar

ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.